» Go to news main
Dal PhD candidate among elite young scientists nominated to attend Lindau Nobel Laureate meeting
Award-winning Dalhousie PhD student Simon Gebremeskel is a pioneer in discovering how the immune system can fight cancer.
Gebremeskel is working with Dr. Brent Johnston in Dalhousie Medical School’s Department of Microbiology & Immunology to develop a cancer treatment that kills cancer cells by both activating the immune system and introducing viruses that kill cancer cells. This novel combination strategy — of immunotherapy plus oncolytic viruses — could be available within a few years.
“What's becoming clear in the field of cancer therapy is the majority of cancer patients should be looked at as patients who have immune deficiency,” says the Kenyan-born scientist, who did his undergraduate degree at Queen's University. “Normal cells in our body become transformed quite frequently into pre-cancerous or early-stage cancer cells. Evidence suggests the immune system is able to recognize these changed cells and clear them off.”
Read more on Dal News.
Recent News
- Leading the way: Dal’s 2024 university wide teaching award winners exemplify excellence in higher ed
- Faculty of Medicine presents awards at annual faculty meeting
- Dalhousie Stands Out Amid National Downward Matching Trend
- Dr. Sara Folkins receives C. B. Stewart Medal recognizing academic excellence
- Channelling the power of Natural Killer cells to beat cancer
- Rare disease specialist returns to Dalhousie
- Ophthalmologist, author receives Gold‑Headed Cane Award
- Celebrating the Class of 2024